What should we be telling relatives of people with type 1 diabetes
In the sixth of our 2022 ABCD webinar series, please join Dr Parth Narendran to discuss 'What should we be telling relatives of people with type 1 diabetes?
The type 1 diabetes landscape is rapidly changing on many fronts. One of them is in the delay and prevention arena. The last few years have seen unprecedented changes in this space and we are approaching a time when therapies to delay type 1 diabetes may become available.
This webinar will bring the audience up to speed with progress in this area and concentrate on screening to identify people at risk of type 1 diabetes to whom these therapies can be offered. Since there is a significant genetic contribution to the development of type 1 diabetes, it is likely that family members will be some of the first to step forward to ask about and participate in screening programmes. This webinar will outline some of the information we should be passing on to them.
Q& A will follow this presentation
RCP Accreditation has been sought for this webinar. Certificates of attendance will be issued to those who attend the live webinar.
Parth’s clinical interests focus on type 1 diabetes and he supports the type 1 services at the Queen Elizabeth Hospital, Birmingham. These include a structured education programme called Dose Adjustment for Normal Eating (DAFNE), the adolescent transition, insulin pump, glucose sensing and islet/pancreas transplant services. Supporting patients to exercise is a core interest of the service.
Parth’s research interests also focus on type 1 diabetes. He has a long-standing interest in preserving the function of insulin producing pancreatic beta cells in type 1 diabetes. Over the years he has been fortunate to receive funding from Diabetes UK, JDRF, DRWF, Wellcome Trust, MRC, The Insulin Dependent Diabetes Trust as well as the National Institute for Health Research.
At the University he leads a group that researches how to encourage and support patients with type 1 diabetes to exercise. Studies he has conducted include; EXTOD education a study that aims to develop and pilot an education programme for people with Type 1 diabetes (with accompanying training for health care professionals to deliver this programme) to guide insulin and carbohydrate adjustment for safe exercise; Type 1 HIT a study that aims to determine whether High intensity interval training is an efficient and effective form of exercise for people with Type 1 diabetes and EXTOD 101 a study that aims to determine the “real world” risks and benefits of exercise in 101 adults with type 1 diabetes who are training for and running a Half Marathon.
At Musgrove park hospital as well as doing regular Diabetes and obesity clinics he runs specialist adult, adolescent and paediatric sports clinics to give advice to sports men, women and children who have Type 1 diabetes.
